Clinical Trials Directory

Trials / Completed

CompletedNCT03062917

Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis

Validation of Nasal and Bronchial Absorption Sampling Methods for the Assessment of RSV Bronchiolitis in Babies and Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
152 (actual)
Sponsor
Imperial College Healthcare NHS Trust · Academic / Other
Sex
All
Age
2 Weeks – 2 Years
Healthy volunteers
Accepted

Summary

This study will compare the novel methods of NS and BS with the standard technique of nasophayngeal aspiration (NPA) and routine ETT suction. We shall assess the samples for diagnosis of RSV, viral load and immune responses in the airways of babies with RSV infection. We shall also assess the genetics of babies included in this study, to see if they may be vulnerable to RSV infection.

Detailed description

In conjunction with a specialist medical device manufacturing company (Hunt Developments (Midhurst, West Sussex) we have produced novel nasosorption and bronchosorption kits that have CE marking. Both nasosorption and bronchosorption methods use synthetic absorptive matrix (SAM) strips: that look and feel like blotting paper, and will be placed onto the mucosal surface. These are comfortable to use and can be used at frequent intervals over extended periods of time. This non-invasive technique is ideal for infants and children, and it is possible to obtain neat mucosal lining fluid (MLF) even from normal healthy noses. The eluates contain cytokines and chemokines at high detectable levels on multiplex immunoassay. We would like to use these SAMs to take MLF samples from the nasal and bronchial mucosal surfaces to see if these novel techniques can overcome the problems with current sampling methods. We plan to use these absorption techniques to measure RSV viral load. We also aim to look at the immune response in terms of the anti-viral interferon response (IFN-γ, IFN-λ, IFN-α2a, IP10, ITAC). In therapeutic studies in the future, it may be possible to document levels of drug (pharmacokinetics) in nasal MLF.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNasal and Bronchial SamplingNasal Absorption sampling, Bronchial sampling, Nasal Pharageal Aspirates, Blood sampling.

Timeline

Start date
2015-10-02
Primary completion
2018-06-30
Completion
2018-06-30
First posted
2017-02-24
Last updated
2019-11-12
Results posted
2019-11-12

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03062917. Inclusion in this directory is not an endorsement.